首页 › 基金 › PERCEPTIVE ADVISORS LLC › LKFT

PERCEPTIVE ADVISORS LLC 对 LKFT 的持仓历史

LAKEFRONT BIOTHERAPEUTICS NV

PERCEPTIVE ADVISORS LLC 在 Q3 2026 的 13F 申报中披露持有 LKFT(LAKEFRONT BIOTHERAPEUTICS NV)1,242,404 股,市值约 US$36.8M,约占其申报组合的 0.71%,在其申报持仓中市值排名第 29 位。 PERCEPTIVE ADVISORS LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)1.24M 股
申报持仓市值$36.84M
组合权重0.71%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

PERCEPTIVE ADVISORS LLC 对 LKFT 的持仓演变

PERCEPTIVE ADVISORS LLC 于 Q3 2026 首次披露 LKFT 持仓:1,242,404 股(约 US$36.8M)。

逐季持仓明细

季度股数金额变化
Q3 2026 1.24M $36.84M 新进

关于 LKFT 与 13F 数据

LKFT(LAKEFRONT BIOTHERAPEUTICS NV)的行业分类暂缺。我们追踪的基金中还有 17 只申报持有 LKFT,申报仓位最大的包括:GILEAD SCIENCES, INC. (US$501.3M), TANG CAPITAL MANAGEMENT LLC (US$118.2M), Madison Avenue Partners, LP (US$104.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 LKFT 的基金

查看 LKFT 的全部基金持有人 →

常见问题

How long has PERCEPTIVE ADVISORS LLC held LKFT?

PERCEPTIVE ADVISORS LLC has disclosed LKFT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is PERCEPTIVE ADVISORS LLC's current position in LKFT?

As of Q3 2026, PERCEPTIVE ADVISORS LLC holds 1.24M shares of LKFT (LAKEFRONT BIOTHERAPEUTICS NV), valued at $36.84M, representing 0.71% of its reported portfolio and ranking #29.

Has PERCEPTIVE ADVISORS LLC been buying or selling LKFT?

In the latest 13F filing (Q3 2026), PERCEPTIVE ADVISORS LLC newly opened its position in LKFT.

Which other funds hold LKFT?

Other major institutional holders of LKFT include GILEAD SCIENCES, INC., TANG CAPITAL MANAGEMENT LLC, Madison Avenue Partners, LP, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.